ReP USP - Resultado da busca

Filtros : "ANTIDEPRESSIVOS" "IB" Removido: "ESTRESSE" Limpar

Filtros

USP affiliated authors
- markus, regina pekelmann (~2)
Date published
- 2011 (~2)
Subjects
- antidepressivos (~2)
- depressão (~2)
- melatonina (~2)
Language
- inglês (~2)
Source title
- biological psychiatry (~1)
- human psychopharmacology-clinical and experimental (~1)
Publisher
Conference titles
- annual scientific convention and meeting (~1)
Countries/Territories
- estados unidos (~1)
- reino unido (~1)
Grupo de pesquisa
Funding Agencies
Indexado em
- indexado no: pubmed (~1)
- indexado no: scopus (~1)
- indexado no: web of science (~1)
Collaboration
Normalized affiliation
Non normalized affiliation
- department of pharmacology, institute of basic health sciences, federal university of rio grande do sul, porto alegre, rio grande do sul, brasil (1)
- department of psychiatry and forensic medicine, faculty of medicine, federal university of rio grande do sul and laboratory of chronobiology of hospital de clínicas de porto alegre, rio grande do sul, brasil (1)
- department of psychiatry and forensic medicine, faculty of medicine, federal university of rio grande do sul, porto alegre, brasil (1)
- developmental cognitive neuroscience - postgraduate program in psychology (1)
- faculty of medicine, federal university of rio grande do sul, porto alegre, rio grande do sul, brasil (1)

Trabalho de evento-resumo periodico
6-Sulfatoximelatonin as a predictor of clinical outcome in depressive patients treated with inhibitors of monoamine uptake (2011)
Pezzi, Julio Carlos; Dantas, Giovana; Hidalgo, Maria Paz Loayza; Grassi-Oliveira, Rodrigo; Markus, Regina P
Source: Biological Psychiatry. Conference titles: Annual Scientific Convention and Meeting. Unidade: IB
Subjects: DEPRESSÃO, ANTIDEPRESSIVOS, MELATONINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEZZI, Julio Carlos et al. 6-Sulfatoximelatonin as a predictor of clinical outcome in depressive patients treated with inhibitors of monoamine uptake. Biological Psychiatry. Philadelphia: Instituto de Biociências, Universidade de São Paulo. . Acesso em: 16 nov. 2024. , 2011
APA
Pezzi, J. C., Dantas, G., Hidalgo, M. P. L., Grassi-Oliveira, R., & Markus, R. P. (2011). 6-Sulfatoximelatonin as a predictor of clinical outcome in depressive patients treated with inhibitors of monoamine uptake. Biological Psychiatry. Philadelphia: Instituto de Biociências, Universidade de São Paulo.
NLM
Pezzi JC, Dantas G, Hidalgo MPL, Grassi-Oliveira R, Markus RP. 6-Sulfatoximelatonin as a predictor of clinical outcome in depressive patients treated with inhibitors of monoamine uptake. Biological Psychiatry. 2011 ; 69( 9 suppl.): 1345 res. 450.[citado 2024 nov. 16 ]
Vancouver
Pezzi JC, Dantas G, Hidalgo MPL, Grassi-Oliveira R, Markus RP. 6-Sulfatoximelatonin as a predictor of clinical outcome in depressive patients treated with inhibitors of monoamine uptake. Biological Psychiatry. 2011 ; 69( 9 suppl.): 1345 res. 450.[citado 2024 nov. 16 ]
Artigo de periodico
6-Sulfatoxymelatonin as a predictor of clinical outcome in depressive patients (2011)
Hidalgo, Maria Paz Loayza; Caumo, Wolnei; Dantas, Giovana; Franco, Daiane Gil; Torres, Iraci Lucena da Silva; Pezzi, Julio; Elisabetsky, Elaine; Detanico, Bernardo Carraro; Piato, Ângelo; Markus, Regina P
Source: Human Psychopharmacology-Clinical and Experimental. Unidade: IB
Subjects: MELATONINA, DEPRESSÃO, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIDALGO, Maria Paz Loayza et al. 6-Sulfatoxymelatonin as a predictor of clinical outcome in depressive patients. Human Psychopharmacology-Clinical and Experimental, v. 26, n. 3, p. 252-257, 2011Tradução . . Disponível em: https://doi.org/10.1002/hup.1204. Acesso em: 16 nov. 2024.
APA
Hidalgo, M. P. L., Caumo, W., Dantas, G., Franco, D. G., Torres, I. L. da S., Pezzi, J., et al. (2011). 6-Sulfatoxymelatonin as a predictor of clinical outcome in depressive patients. Human Psychopharmacology-Clinical and Experimental, 26( 3), 252-257. doi:10.1002/hup.1204
NLM
Hidalgo MPL, Caumo W, Dantas G, Franco DG, Torres IL da S, Pezzi J, Elisabetsky E, Detanico BC, Piato Â, Markus RP. 6-Sulfatoxymelatonin as a predictor of clinical outcome in depressive patients [Internet]. Human Psychopharmacology-Clinical and Experimental. 2011 ; 26( 3): 252-257.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/hup.1204
Vancouver
Hidalgo MPL, Caumo W, Dantas G, Franco DG, Torres IL da S, Pezzi J, Elisabetsky E, Detanico BC, Piato Â, Markus RP. 6-Sulfatoxymelatonin as a predictor of clinical outcome in depressive patients [Internet]. Human Psychopharmacology-Clinical and Experimental. 2011 ; 26( 3): 252-257.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/hup.1204

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024